Short Interest in BioCorRx Inc. (OTCMKTS:BICX) Rises By 23.9%

BioCorRx Inc. (OTCMKTS:BICX) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 8,800 shares, a growth of 23.9% from the March 15th total of 7,100 shares. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is presently 1.2 days. Currently, 0.1% of the shares of the company are short sold.

BioCorRx Stock Performance

BICX opened at $0.29 on Tuesday. The stock has a market cap of $4.84 million, a price-to-earnings ratio of -0.55 and a beta of 0.06. The firm’s fifty day moving average is $0.38 and its 200 day moving average is $0.38. BioCorRx has a fifty-two week low of $0.26 and a fifty-two week high of $1.48.

BioCorRx (OTCMKTS:BICX) last released its quarterly earnings data on Monday, March 31st. The company reported ($0.08) earnings per share for the quarter.

About BioCorRx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.